[Initial results of using Cardioplegin in heart operations].
D000293:Adolescent; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005112:Extracorporeal Circulation; D006324:Heart Arrest, Induced; D006330:Heart Defects, Congenital / Q000601:surgery*; D006349:Heart Valve Diseases / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006801:Humans; D007036:Hypothermia, Induced; D007223:Infant; D007545:Isoproterenol / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use*; D013012:Sorbitol / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D004338:Drug Combinations; D001224:Aspartic Acid; D011343:Procaine; D013012:Sorbitol; C006915:Cardioplegin; D007545:Isoproterenol
Pŭrvi rezultati ot prilozhenieto kardioplegin pri sŭrdechni operatsii.